AND DEVELOPMENT
Thyrotropin-releasing hormone (TRH), a tripeptide synthesized
in the hypothalamus, stimulates the release of pituitary
thyroid-stimulating hormone (TSH). Pituitary TSH is a glycoprotein
that stimulates the synthesis and release of thyroid
hormones by the thyroid gland. Thyroid function develops
in three stages. At the end of the first trimester, the gland
descends from the floor of the primitive oral cavity to its
definitive position in the anterior lower neck. The hypothalamicpituitary-thyroid axis becomes functional in the second
trimester. Peripheral metabolism of thyroid hormones matures
in the third trimester.
Thyroxine (T4), triiodothyronine (T3), and TSH do not
cross the placenta in significant amounts. Concentrations in
fetal serum reflect primarily fetal secretion and metabolism.
Maternal thyroid antibodies, iodides (including radioactive
iodides), and medications given to mothers to treat hyperthyroidism
(methimazole and propylthiouracil) cross the
placenta and affect fetal thyroid function. An infant born prematurely
or with intrauterine growth restriction may have an
interruption of the normal maturational process and appear to
have hypothyroidism by standard tests.
The thyroid gland concentrates iodine and binds it to
tyrosine molecules to produce either monoiodotyrosine or
diiodotyrosine, with subsequent coupling of two tyrosines, T4
or T3. The major fraction of circulating T3 (approximately two
thirds) is derived from peripheral deiodination of T4 to T3, but
some is produced by the thyroid gland itself. The conversion of
T4 to T3 requires the removal of one iodine from the outer ring